orphenadrine has been researched along with Cardiovascular Stroke in 1 studies
Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seo, KW | 1 |
| Park, JS | 1 |
| Tahk, SJ | 1 |
| Shin, JH | 1 |
1 other study available for orphenadrine and Cardiovascular Stroke
| Article | Year |
|---|---|
A Case of Acute Myocardial Infarction Induced by Selective Cyclooxygenase-2 Inhibitor.
Topics: Calcium Channel Blockers; Cyclooxygenase 2 Inhibitors; Diclofenac; Humans; Male; Middle Aged; Myocar | 2017 |